The bull thesis for MRNA and and PFE beyond the Public Health Emergency has consisted, in part, of wringing a higher price out of commercial insurers - something former White House Advisor, Andy Slavitt, has thrown cold water on - and applying the mRNA technology to other vaccines and uses beyond SARS-CoV-2. Dr. Bhargava has done extensive research in this area and offers a salient and objective view of the current state of the research.
|
Connection Details: Today, 12:30 PM ET (Add to Outlook) Live Video Only. Link here: https://app.hedgeye.com/feed_items/121756?with_category=48-health-policy (Last minute, I know. So look for replay link later today!) |
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn
